Intrauterine adhesion (IUA) is characterized by endometrial fibrosis, which ultimately leads to menstrual abnormalities, infertility, and recurrent miscarriages. The Shh/Gli2 pathway plays a critical role in tissue fibrogenesis and regeneration; Gli2 activation induces profibrogenic effects in various tissues, such as the liver and kidney. However, the role of Gli2 in endometrial fibrosis remains unknown. The purpose of this study was to test the hypothesis that activated Gli2 promotes endometrial fibrosis. Endometrial samples from moderate and severe IUA patients exhibited significantly enhanced expression of Gli2 compared with normal endometrial samples and mild IUA samples. Transfection with overactive Gli2 plasmids induced higher fibrosis-related protein expression, while blocking Gli2 signaling with cyclopamine caused the opposite effect in endometriotic stromal cells (ESCs), including inducing cell-cycle arrest. Menstrual-derived stem cell conditioned medium (MenSCs-CM) reduced endometrial fibrosis by reducing Gli2 protein levels and causing cell-cycle arrest in ESCs through granulocyte-colony stimulating factor (G-CSF). The effect was weakened after neutralization with a G-CSF antibody. Gli2 overexpression reduced the effects of MenSC-CM and G-CSF on fibrosis and cell-cycle progression in vitro. The antifibrotic effect of G-CSF was also observed in murine model. These findings demonstrate that Gli2 signaling
Background
Intrauterine adhesion (IUA), also known as Asherman syndrome, indicates partial or complete fibrosis within the uterine cavity due to damage to the basal endometrial layer, leading to conditions such as menstrual abnormalities, infertility, recurrent miscarriages, and severe pelvic pain. IUA is primarily caused by curettage or various forms of hysteroscopic surgery, including resection of septa, polyps, and solitary or multiple fibroids [1] . Currently, transcervical resection of adhesion followed by estrogen supplement has been the method of choice in treating this disease [2] ; however, the recurrence of IUA is high, especially in severe cases. Therefore, novel therapies that target the cellular and molecular mechanisms underlying endometrial fibrosis are required.
The endometrium comprises a single-layer columnar epithelium atop stromal cells. The stroma is a layer of connective tissue that varies in thickness according to periodic hormonal influences [3] . In women of reproductive age, the endometrium undergoes stripping and bleeding at menses and can be built up without scarring in subsequent cycles [4] . The regenerative capacity of the endometrium hints that stem cells may exist in this compartment that plays crucial roles in uterine homeostasis and regeneration [5] . Research aimed at identifying epithelial-and stromal-derived stem cells has revealed the presence of stem cells in the human endometrium. It is notable that endometrial mesenchymal stem-like cells (eMSCs) from the menstrual phase undergo significantly more rounds of self-renewal and have the capacity to generate a greater cell output than those from the secretory phase, suggesting that eMSCs are activated in the menstrual phase for the cyclical regeneration of the endometrium [6] . Loss of endometrial stem cells may be responsible for the inability to repair the endometrium in IUA patients [7] . Intercellular communication based on the paracrine activity of MSCs is regarded as the major mechanism of tissue repair [8] . Our previous study showed that the paracrine function of human menstrual blood-derived endometrial mesenchymal stem cells (MenSCs) could promote neovascularization and the repair of impaired endometrium, ultimately improving fertility in mice [9] . Meanwhile, another study showed that bone marrow stem cell (BMSC) transplantation was effective in repairing damaged endometrium, likely through promoting estrogen receptor and progesterone receptor expression [10] . Despite these data, the precise mechanism of stem cell therapy requires further investigation. Finding an important factor for stem cell therapy would be a milestone for the development of novel cell-free treatments that might overcome the difficulties and risks associated with the clinical application of stem cells.
The Hedgehog (Hh) signaling pathway regulates many critical cellular functions including proliferation, apoptosis, migration, and differentiation, and plays an important role in tissue repair [11] . Cellular responses to Hh are initiated by ligand binding to the membrane receptor Patched1, which releases active Smoothened (smo). Active smo initiates the intracellular Hh cascade, which ultimately leads to the activation and nuclear translocation of Gli family transcription factors [12] . Growing evidence implicates a critical role for the Hh pathway in tissue fibrosis. Some evidence suggests that Hh pathway activation promotes epithelial-to-mesenchymal transition and contributes to tissue fibrosis in the liver, kidney, and other organs [13] [14] [15] . Additionally, the Hh pathway favors Gli2 protein stabilization by inhibiting its proteasome degradation [16] . Accumulating data also indicates that Gli protein can be activated in a ligand-independent fashion by TGF-β [17, 18] , which has also been reported to contribute to fibrosis progression [19, 20] . Moreover, there is research suggesting that drug-induced Gli2 silencing in the kidney can attenuate myofibroblast cell-cycle progression and reverse renal fibrosis [13] . However, the role of Gli2 protein in endometrial fibrosis is still unknown.
Given the function of MSCs in normal endometrial homeostasis and injury repair, the mechanism is complicated. Granulocyte-colony stimulating factor (G-CSF), a glycoprotein employed to treat neutropenia, stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. It was also found in ovary, endometrium, and placenta, being involved in ovulation, embryo implantation, placental growth, and embryo development [21] . It was reported the G-CSF and GM-CSF were the highest concentration of cytokine in endometrial stem cell supernatant but could not be detected in that of BMSC [22] . Hence, we tried to find out whether MenSCs-CM reverse the endometrial fibrosis conducted by transcription factor Gli2 through G-CSF. These findings would have important diagnostic and therapeutic implications for individuals with IUA and thus, provide a new direction for endometrial fibrosis treatment.
Methods

Samples
Fresh endometrium of proliferative phase of 24 IUA patients (8 mild IUA patients, 16 moderate and severe IUA patients) and 13 healthy volunteers at the Sir Run Run Shaw Hospital, Zhejiang University Medical College, Hangzhou, China were collected for this study. Samples were preserved at -80
• C or in liquid nitrogen. Detailed clinical information for all the cases is available (Supplementary Table S1 ). Tissues were macrodissected for RNA extraction. Those surgically removed tissues, remaining after pathological diagnosis, were used to this study with written informed consent from patients. This study, including the content procedures, was approved by the ethical committee of Sir Run Run Shaw Hospital, Zhejiang University Medical College, China (No:20150227-23).
Animals
Female Sprague Dawley rats were obtained from the Experimental Animal Center of Zhejiang Province (Hangzhou, China) and maintained in the Animal Facility of Sir Run Run Shaw Hospital, Zhejiang University. Five to six mice per cage were housed in a room with a 12-h light/dark cycle and provided access to food and water ad libitum. All animals were treated according to a protocol approved by the institutional animal care and use committee of Zhejiang University. Animal handlers were blinded to the experimental groups; obtained tissues were also examined in a blinded fashion.
Establishing the rat endometrial fibrosis model with 95% ethanol
The endometrial fibrosis model was set up by injecting 95% ethanol into the uterus of rats according to a preliminary study [23] . After administering 8% chloral hydrate (0.5 ml/10 g) by intraperitoneal injection, a vertical incision was made in the abdominal wall, fully exposing the uterine horns. Right uterine horns were stretched into a straight line, and 95% ethanol (approximately 0.4 ml) was injected with a 1-ml syringe for 3 min, and then repeatedly washed with normal saline using another 1-ml syringe. The left horns remained untreated as internal controls. The uteri were then disinfected and replaced into the cavity.
Groups and treatment
By observing vaginal smears, all rats were in the proliferative phase. After the model was created, rats were randomly divided into six groups: (1 and 2) infused with 0.5 ml G-CSF (100 μg/0.6 ml, rhG-CSF, Qilu Pharmaceutical Co., Ltd) into the uterine cavity immediately after model generation, and then 50 μl G-CSF (100 μg/0.6 ml) was subcutaneously administered daily until sacrifice 7 or 14 days after modeling (G-CSF groups, n = 6 for both time points); (3 and 4) infused with 0.5 ml sodium chloride (NaCl) into the uterine cavity immediately after model generation, and then 50 μl NaCl was administered subcutaneously daily similar to the G-CSF group (NaCl groups, n = 6 for both time points). The condition of the animals was monitored daily after surgery; (5 and 6) two groups received intraperitoneal injection of cyclopamine daily (Selleck) 5 and 15 mg/kg, respectively for 2 weeks. After treatment, all rats were anesthetized by an intraperitoneal injection of an overdose of 8% chloral hydrate and the bilateral horns from each group were removed and placed into 4% paraformaldehyde for histopathological examination.
Primary ESC culture
Endometriotic stromal cells (ESCs) were isolated from normal endometrium after receiving signed informed consent letters from patients; these procedures were approved by the ethics committee of Sir Run Run Shaw hospital (No. 20120222-32) . ESCs were extracted and cultured as described by Nasu et al. [24] . Briefly, endometrial tissue was repeatedly rinsed with sterile phosphate-buffered saline (PBS) and cut into 0.5-1 mm 3 fragments with ophthalmic scissors, and digested with collagenase solution (0.1%, Catalog#: 17100-017, Life Technologies, USA) for 1 h at 37 • C; the plate was gently shaken every 15-20 min during digestion. The digestion reactions were terminated with DMEM/F12 containing 10% fetal bovine serum (FBS), and samples were filtered through wire sieves with various pore sizes to remove cell impurities and epithelial cells, centrifuged at 800 g for 5 min, resuspended in DMEM/F12 containing 10% FBS, and incubated in a 5% CO 2 incubator at 37
• C. The culture medium was changed every 2-3 days. When the primary ESCs grow to 90% confluence, cells were trypsinized and reseeded; cells were passaged every 3-4 days. ESCs within 10 passages were used for the following experiments. ESCs were treated with MenSCs-CM, 200 ng/ml G-CSF, and 0.05 μg/ml smo inhibitor Cyclopamine (Cat. No. 1623/1, TOCRIS) respectively, then their RNA and protein were extracted for Q-PCR or western blot, and cells were used for the analysis of cell cycle with flow cytometry.
Mesenchymal stem cells culture
MenSCs were isolated and provided by the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University [9, [25] [26] [27] . Briefly, human menstrual blood was collected using a Diva cup (Evans Biotech, Hangzhou, China). Cells were transferred into PBS with mixed antibiotics, including amphotericin B, gentamycin sulfate, kanamycin sulfate, cephalexin, vancomycin hydrochloride, and heparin at 4
• C for 24 h. Then, the samples were centrifuged at 1600 g for 10 min at 4
• C, and supernatants were used for microbiological testing. Mononuclear cells were separated by FicollPaque (1.077 g/ml) density-gradient centrifugation (Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions. Purified mononuclear cells were cultured in Chang Medium [28] overnight at 37
• C incubator. Cells were trypsinized and passaged every 3-4 days. Cells were used for experiments until they reached 80%-90% confluence. The expression of cell surface markers CD29, CD90, CD34, CD45, CD117, HLA-DR, and OCT4 was measured in MenSCs, and the cells were characterized for their capability to differentiate into adipocytes, osteoblasts, and chondroblasts. Culture medium was changed every 3 days. Only cells of passages 5-9 were used in experiments.
Preparation of menstrual-derived stem cell conditioned medium
MenSCs-CM was collected as previously described [9] . Briefly, 5 × 10 5 MenSCs/ml were seeded and cultured for 24 h in Chang
Medium. Then, the medium was replaced with 10 ml DMEM, and cells were cultured for an additional 48 h. Culture supernatants were collected and centrifuged at 1000 g for 3 min to remove cells and debris. The clarified supernatant was then concentrated with a 3K nominal molecular weight limit Filter Device (Merck Millipore, Billerica, MA, USA) at 4000 g for 60 min, filtered through a 0.22 μm filter and stored at -70 • C until use.
Protein chip
Quantibody R Array Glass Chip (Catalog#: AAH-CYT-1000, RayBiotech) was used to quantitatively determine the concentration of cytokines secreted by MenSCs. We performed the protein chip as the protocol provided by the manufacturer. Briefly, we added 100 μl sample diluent of blocking buffer into each well of the slides and incubated at room temperature for 30 min to block slides. Then, we added 100 μl MenSCs-CM (concentration 100×, three copies) to each well and incubated arrays at room temperature for 1-2 h. After two times washes, the chip slide was incubated with Biotinylated Antibody Cocktail for 2 h, and then decanted the samples from each well and washed five times. After briefly spinning down, we added 80 μl of Cy3 equivalent dye-conjugated streptavidin to each well, and then covered the device with aluminum foil at room temperature for 1 h, avoiding exposure to light. Finally, the slides can be visualized through the use of a laser scanner (InnoScan 300 Microarray Scanner, France) equipped with a Cy3 wavelength (wavelengh: 532 nm; resolution: 10 μm).
Western blotting
After treatment, ESC protein content was extracted with RIPA Lysis Buffer for 30 min. The lysate was centrifuged at 12 000 g for 20 min at 4
• C. The supernatant was collected, and the protein concentration was determined using the BCA protein assay. To detect Gli2 and markers related to cell cycle and fibrosis, proteins from each group were denatured and subjected to 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis and then transferred to a polyvinylidene fluoride membrane. After blocking with 5% dry milk in Tris-buffered saline with 0.1% TWEEN, membranes were incubated overnight at 4
• C with primary antibodies, and then secondary antibodies for 2 h at room temperature the following day. Immunoreactivity was detected using enhanced chemiluminescence. Equal amounts of protein were verified by reprobing the membrane with an anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody. Immunoreactive bands were visualized using ECL for chemiluminescence detection and analyzed with ImageJ software 3.0. Primary antibodies were listed in the Table 1 .
Quantitative real-time transcription PCR
Total RNA was extracted from cells using Trizol (Invitrogen, Carls the endogenous GAPDH reference ( Ct), and then further normalized to the quantity of target mRNA in the control group, which was defined as 1.
Cell cycle analysis by flow cytometry
ESCs cultured in complete medium were seeded in 10-cm plates at a concentration of 5 × 10 5 cells/plate and allowed to attach overnight.
Cells were treated as indicated, and then trypsinized. After fixing in 75% ethanol at 4
• C overnight, cells were washed in PBS twice and incubated with 100 ng/ml ribonuclease (RNase) and 10 ng/ml propidium iodide in PBS for 30 min in the dark at 37
• C. Flow cytometry was performed to detect cell-cycle distributions. Data were analyzed using ModFit LT 3.2 software (Verity Software House, Topsham, ME, USA). Results are expressed as the mean values of three experiments.
Transient transfection
Gli2 plasmid was generously donated by the Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China, and used for transfection. Briefly, cells were seeded in six-well plates and cultured to 70% confluence before transfection. Transient transfections of Gli2 in ESCs were performed using X-treme GENE HP DNA transfection Reagent (Roche, Basel, Switzerland) according to the manufacturer's protocols. In each 6-cm plate, cells were transfected with 500 μl Opti-MEM Reduced Serum Medium, 5 μg Gli2 plasmid DNA, and 5 μl transfection reagent for 8 h in the absence of serum, and then, the cells were cultured in complete media for 48 h.
Hematoxylin and eosin, immunohistochemistry, and Masson trichrome staining
Uterine horns were collected, fixed with 4% paraformaldehyde, embedded in paraffin, and then 4-μm serial sections were prepared for histopathological examination. Sections were subjected to hematoxylin and eosin, immunohistochemistry (IHC), and Masson trichrome staining. For Masson trichrome staining, sections were stained according to routine procedures [29] ; collagen fibers were bluish-green. The percent fibrosis was calculated as the area of fibrosis divided by the area of tissue using Image J software.
IHC was performed with a rabbit monoclonal antibody against human collagen I (Col-I; 1:200; Abcam). The staining score of Col-I was calculated according to an H-score equation: H score = Pi (i + 1), where i is the intensity of staining (0 = negative, 1 = weak, 2 = moderate and 3 = strong) and Pi is the percentage of cells stained at each intensity (0%-100%). Two observers independently scored the sections.
Statistical analysis SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. The data are presented as mean ± standard deviation. Comparisons between groups were done using the Student t-test and one-way ANOVA followed by the appropriate post hoc test to determine statistical significance. All in vitro experiments were repeated and analyzed at least in triplicate. The results were considered significant when P < 0.05.
Results
The functional involvement of Gli2 in endometrial fibrosis of IUA patients and ESCs
With the aim of uncovering the molecular mechanism of endometrial fibrosis, we first compared the expression level of Gli2 in normal endometrium and IUA by IHC and western blot, and found significantly higher Gli2 expression in IUA patients ( Figure 1A and B) . Also, we found the severer the endometrial fibrosis, the higher Gli2 expression ( Figure 1C) . Furthermore, Gli2 overexpression by transient transfection also induced increased Col I, αSMA, and CTGF expression in ESCs, suggesting that Gli2 protein could induce fibrosis in vitro ( Figure 1D ).
Gli2 overexpression accelerates ESC cell-cycle progression, while cyclopamine restrains ESC division and alleviates fibrosis
Several studies have reported that Hh signaling regulates cell proliferation in developmental and disease settings [30] [31] [32] [33] ; the cell cycle is the key process that regulates cell proliferation. To further elucidate whether Gli2 affects fibrosis by influencing ESC cell-cycle progression in vitro, we upregulated or downregulated Gli2 activity by transient Gli2 transfection or treatment with the smo inhibitor cyclopamine, respectively. The results showed that Gli2 overexpression increased Cyc A2, Cyc B1, and Cyc E2 expression and reduced levels of the cyclin-dependent kinase inhibitors p21 and p27, indicating that Gli2 promotes ESCs passing through critical cell-cycle checkpoints ( Figure 2 ). Flow cytometric analysis of cell-cycle distributions further revealed that Gli2 overexpression resulted in G 0 /G 1 progression, as more cells were in the S and G 2 /M phases. In contrast, cyclopamine decreased the expression of protein associated with cell-cycle progression (Cyc A2, Cyc B1), and limited Col I, CTGF, and αSMA expression, which were all confirmed by western blot ( Figure 2D and E). Consistent with these results, Gli2 reduction by cyclopamine led to a G 0 /G 1 arrest, with fewer cells in the S and G 2 /M phases ( Figure 2F and G).
MenSCs-CM reduces ESC fibrosis and induces a cell-cycle arrest in vitro through G-CSF
Previous studies have indicated that stem cell-conditioned medium can inhibit tissue fibrosis [9, 10] . In accordance with these reports, we also found that MenSCs-CM could inhibit the expression of fibrosisrelated proteins Col I, αSMA, and CTGF in a time-dependent manner ( Figure 3A) . Next, we verified whether MenSCs-CM achieved its antifibrotic effect in ESCs by affecting Gli2 expression. To our surprise, we found that MenSCs-CM could not only inhibit Gli2 protein expression, but also could influence cell-cycle progression in exact opposition to Gli2 overexpression, indicating that MenSCs-CM may exert its role through Gli2. Subsequently, we applied protein chip technology to detect specific molecules within MenSCs-CM, and found that MenSCs secreted high level of G-CSF (Supplementary Figure S1 ). Next, we treated ESCs with CM or CM neutralized with an anti-G-CSF antibody to clarify the role of G-CSF during the fibrosis. We found that neutralizing G-CSF within CM attenuated its antifibrotic effect. Cell-cycle analysis found that neutralizing G-CSF induced more cells going through the S-phase checkpoint, as more cells were in the G 2 /M phase ( Figure 3 ).
G-CSF ameliorates ECS fibrosis via reducing Gli2 protein levels and inducing cell-cycle arrest
As MenSCs-CM inhibits Gli2 expression, and neutralizing G-CSF attenuates the role of CM in reducing fibrosis, we wished to know whether only adding G-CSF could alter Gli2 protein levels and the expression of cell-cycle regulators in ESCs in vitro. Messenger RNA and protein analyses from ESCs treated with only G-CSF for different durations showed that G-CSF reduced fibrosis and downregulated Gli2 and cyclins, which control cell-cycle progression. Furthermore, flow cytometric analysis of the cell-cycle distribution revealed that more cells were in the G 0 /G 1 phase after G-CSF treatment compared with controls. These data suggested that the antifibrotic effect of G-CSF might be related to its effect on Gli2 protein level and the cell cycle, indicating that antifibrotic activity of MenSCs was primarily through G-CSF (Figure 4 ).
Gli2 overexpression reverses effects of MenSCs-CM and G-CSF
Gli2 overexpression promoted ESC proliferation and led to the development of fibrosis, while reducing Gli2 expression with G-CSF treatment caused cell-cycle arrest and inhibited fibrotic progression, suggesting that Gli2 was a pivotal regulator of endometrial fibrosis. We next investigated whether Gli2 overexpression was sufficient to weaken the inhibitory effects of MenSCs-CM and G-CSF. To this end, Gli2 was overexpressed in ESCs by plasmid transfection. Gli2 overexpression in ESCs blocked the antifibrotic and cell-cycle inhibitory effects of MenSCs-CM and G-CSF ( Figure 5 ), demonstrating that Gli2 is an important molecular target of CM and G-CSF. These data showed that neither CM nor G-CSF had an appreciable effect on Gli2-overexpressing ESCs, further confirming a central role for Gli2 in the cell-cycle inhibitory and antifibrotic effects of G-CSF and CM.
G-CSF and cyclopamine reverses endometrial fibrosis in a rat model
To further investigate the influence of G-CSF on endometrial fibrosis in vivo, we explored the effect of G-CSF on endometrial fibrosis in rats. The right uterine horns of female rats were injured with 95% ethanol as described in the Materials and Methods section, with the left horns serving as internal controls. The level of fibrosis at weeks 1 and 2 in the G-CSF group was significantly lower than in the NaCl groups (P < 0.001, Figure 6 ). Moreover, fibrosis at week 2 was decreased compared with week 1 in the G-CSF group (P < 0.01, Figure 6 ). We did not observe this change in the NaCl group. In addition, cyclopamine can reduce fibrosis. The effect of reducing fibrosis by the use of 15 mg/kg cyclopamine was more obvious than 5 mg/kg cyclopamine.
Discussion
Trauma to the endometrium can cause endometrial injury and hamper endometrial repair, eventually leading to IUAs. However, the precise molecular mechanism of IUAs is unclear. Previously, we found that MenSCs could induce repair and regeneration of an injured endometrium by promoting blood vessel formation [9] . In this study, we demonstrated that Gli2 plays a vital role during the progression of endometrial fibrosis. Furthermore, MenSCs-CM could induce a Gli2-dependent cell-cycle arrest in ESCs and ameliorate endometrial fibrosis via G-CSF.
Our results demonstrate that Gli2 plays a critical functional role in regulating endometrial fibrosis. For IUA patients, the higher Gli2 expression level, the more serious their fibrosis was in their endometrium. We also found that overexpression of Gli2 could induce increased Col I, αSMA, and CTGF expression, while inhibition of Gli2 by cyclopamine presented the opposite results. Accordingly, several studies have reported that the Hh pathway is involved in tissue fibrogenesis in organs such as the liver and kidney [13] [14] [15] [34] [35] [36] . Gli2 is the major transcriptional activator of Hh signaling, which regulates cell-cycle progression and directs proliferation of diverse cell types [37] [38] [39] [40] [41] [42] . During early retinogenesis, Hh signaling increases cell-cycle progression by activating key cell-cycle regulators cyclin D1, cyclin A2, and cyclin B1 [43] . Recently, Kramann et al. reported that Gli inhibition prevented the growth of myofibroblasts by inducing a G 1 cell-cycle arrest through p21 upregulation and a reduction of Rb phosphorylation, which decreased kidney fibrosis [44] . Similar effects involving G 0 /G 1 arrest through Gli2 inhibition or knockout were also observed in osteosarcoma, human vascular smooth muscle cells, and human MSCs [45] [46] [47] . These findings support our observation that Gli2 overexpression by transient transfection drives cell-cycle progression in ESCs, promoting fibrosis, whereas lowering Gli2 levels induces ESCs G 0 /G 1 cycle arrest via the upregulation of p21 and p27 and the downregulation of cyclin proteins. It was reported that Gli1 not Gli2 temporally increased in the glandular during the secretory phase [48] , suggesting that Gli1 may help improve endometrial receptivity. However, we found that Gli2 majorly expressed in proliferative phase endometrium rather than Gli1(data not shown), and inhibition of Gli2 expression can delay the process of the cell cycle of ESCs and reduce endometrial fibrosis, so we believed that Gli2 is the major Gli protein in endometrial regeneration and injury repair. It is well known that MSCs have immunomodulatory and anti-inflammatory properties through secreting cytokines and chemokines. Besides endometrial derived stem cell, G-CSF is also secreted from umbilical cord tissue-derived MSC, playing roles in skin tissue regeneration by hemostasis promoting and inflammation adjusting in early phase, and contributing angiogenesis and wound contraction lately [49] .
In this study, we found that both MenSCs-CM and G-CSF ameliorated endometrial fibrosis, and the G-CSF is unique cytokine in conditioned medium. G-CSF acts in the vascular development of the proliferative endometrium [50] . Some clinical finding illustrates that women with thin endometrium could be benefit from intrauterine G-CSF infusion in in vitro fertilization cycle [51] . Another study confirmed that subcutaneous G-CSF injections promoted the regeneration of thin endometria in animal models [52] . Here we discovered another role of G-CSF in endometrium, as we demonstrated that G-CSF alleviated endometrial fibrosis by arresting cell cycle of endometrial stromal cell in a time-and dose-dependent manner in vitro, the antifibrotic phenomenon represented in vivo. Considering the endometrial repair generally, ameliorating fibrosis is only a part of the comprehensive procedure, and angiogenesis and stem cell homing could be other explanations of stem cell and G-CSF affection.
Based on the role of Gli2 protein and effect of G-CSF in endometrial adhesions, we next investigated whether G-CSF inhibited fibrosis through Gli2. As expected, we found that the antifibrotic effect of CM and G-CSF on ESCs was decreased by Gli2 overexpression, indicating that CM and G-CSF may inhibit fibrosis through Gli2. Although there is no report about the G-CSF governing Gli2 expression or shh signal activity to the best of our knowledge, there was some link between them. In the mouse model of chronic pancreatitis, G-CSF could reduce fibrosis by stimulating macrophage infiltration [53] , and macrophage was found relating to Gli2 production [54] . On other hand, G-CSF can activate RTs-PI3k-AKT pathway [55] , while RTs-PI3k-AKT signal is important in Gli1 regulation [56] . The smo protein was not cut down after adding MenSCs-CM into the stromal cell, so we speculate that there may be another way to govern the Gli2, and deeper excavation is need to go further.
Conclusion
By demonstrating the roles of Gli2 and G-CSF during the formation and reversion of endometrial fibrosis, this study illustrated that G-CSF released from endometrial stem cells reduces endometrial fibrosis by preventing cell cycle progression in stromal cells through Gli2 inhibition. Thus, G-CSF seems to be an innovative adjuvant therapeutic agent for IUAs. However, specific and strict indications for its use in the reproductive field are still not established. Randomized controlled studies are needed to further confirm the effectiveness and safety of G-CSF for antifibrotic therapy.
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